{"database": "press", "table": "releases", "rows": [["https://www.shaheen.senate.gov/news/press/icymi-in-new-editorial-the-eagle-tribune-calls-for-passage-of-shaheens-insulin-act-underscoring-legislations-broad-bipartisan-support", "ICYMI: In New Editorial, The Eagle-Tribune Calls for Passage of Shaheen\u2019s INSULIN Act, Underscoring Legislation\u2019s Broad Bipartisan Support", "2026-10-02", "2026", "2026-10", "Democrat", "Senate", "NH", "Jeanne Shaheen", "S001181", "www.shaheen.senate.gov", "shaheen", "https://www.shaheen.senate.gov/news/press", "scraper", "(Washington, DC) \u2013 In a new editorial titled, \u201cOur View: Politicians can at least agree on insulin price caps,\u201d New Hampshire\u2019s The Eagle-Tribune editorial board expressed its strong support for the INSULIN Act, legislation championed by U.S. Senator Jeanne Shaheen (D-NH), Co-Chair of the U.S. Senate Diabetes Caucus, to cap monthly out-of-pocket insulin costs at $35. The editorial argues that Shaheen\u2019s legislation is a commonsense step Congress can take to protect Americans from being forced to shell out thousands of dollars a year for insulin, and that passage of the bill would be a chance for lawmakers to prove that Congress is still able to deliver bipartisan solutions for the American people.\n\nShaheen\u2019s bipartisan INSULIN Act would cap monthly out-of-pocket insulin costs at $35 a month for all Americans with insurance, expanding the effective price cap for Americans on Medicare. Currently, a majority of states do not have a $35 a month cap on insulin costs. Shaheen\u2019s INSULIN Act would immediately change that, lowering prices for millions and ensuring that the state one lives in doesn\u2019t determine whether they can afford their life-saving insulin. The Eagle-Tribune\u2019s editorial comes as momentum continues to build for the INSULIN Act, with both Senate Democrats and Republicans expressing their support for the legislation in Washington last week.\n\nClick HERE to read the editorial in The Eagle-Tribune. The text of the piece has been provided below.\n\nOur View: Politicians can at least agree on insulin price caps\n\nCongress has a chance to show at least a small bit of bipartisanship by supporting New Hampshire Sen. Jeanne Shaheen\u2019s proposal to make insulin affordable for all Americans.\n\nThe so-called INSULIN Act, of which Shaheen is the lead sponsor, would cap insulin costs at $35 for a month\u2019s supply.\n\nInsulin is already $35 a month for those on Medicare, thanks to the Inflation Reduction Act of 2022.\n\nShaheen\u2019s bill would extend that cap to those who carry private insurance. It would also launch a pilot program in 10 states that would cap insulin costs for uninsured patients.\n\nThe measure would bring some clarity and fairness to the millions of Americans who use the drug to treat their diabetes. Currently, how much you pay depends on how good your insurance is. If you are on Medicare, or you have decent insurance, the cost tops out at $35. If you don\u2019t, you\u2019re often left guessing. It shouldn\u2019t be a crapshoot.\n\nTo its credit, New Hampshire is one of 29 states that has price caps on insulin for those with commercial insurance. A 30-day supply of insulin in the Granite State costs $30. In Massachusetts, the cap is set at $25.\n\nIt makes sense: There is no reason for the cost of insulin to be so high, other than profiteering. Those who need the drug to treat their diabetes have no other option than to use insulin. That allows all manner of jockeying among pharmaceutical companies to squeeze all the profit they can out of the drug, which was first developed a century ago.\n\nWithout the cap, and without decent insurance, the cost of insulin can run into thousands of dollars a year.\n\n\u201cThis is just really overwhelming to have to think about living with this disease for the rest of my life,\u201d Auburn, New Hampshire, 17-year-old Portia Joy said at a Nashua forum organized by Shaheen last month. \u201cAnd I\u2019m contemplating if I\u2019m going to be able to afford the medicine that I need to live.\u201d\n\nIt\u2019s a dilemma faced by many Americans.\n\n\u201cThis is not only the right thing to do,\u201d Shaheen said of her bill, \u201cbut it\u2019s an opportunity for us to provide some relief for so many families who are really struggling with high costs.\u201d\n\nThe bill has a better chance than most of passing in an increasingly divided Congress. Fourteen Republican senators, including Susan Collins of Maine, have signed on in support of the proposal.\n\n\u201cI don\u2019t know why it should divide Republicans,\u201d Sen. Josh Hawley, R-Missouri, told Politico. \u201cWho is in favor of allowing these pharma companies to rip off people with high insulin prices when there is no supply issue or production issue?\u201d\n\nStill, the bill remains a long shot as the November midterm elections approach. The measure has yet to make it to the floor, and there is no House version in the works.\n\nAnd this wouldn\u2019t bankrupt pharmaceutical companies. Eli Lilly, for example, agreed last year to cap what it charges for insulin.\n\n\u201cLilly was the first company to cap what patients pay at $35 per month for all of our insulins, and has been working for years to reduce insulin out-of-pocket costs for people with diabetes, against the headwind of those that benefit from rebates and choose higher list-price medicines over lower-priced options,\u201d company spokesperson Jared Shapiro told Politico.\n\nIf a drug company can cap the price of insulin, why can\u2019t the federal government?\n\n###", 1, "2026-10-03T10:14:25Z", "2026-10-03T10:15:32Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://www.shaheen.senate.gov/news/press/icymi-in-new-editorial-the-eagle-tribune-calls-for-passage-of-shaheens-insulin-act-underscoring-legislations-broad-bipartisan-support"], "units": {}, "query_ms": 0.7072649896144867, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}